Home
Issues
Aim & Scope
Open Access
Editorial Board
Indexing
Why publish with us
Contact us
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Special publications & Reprints
Authorship & COI
Principles of Transparency Checklist
Data Policies
Publication Ethics and Publication Malpractice Statement
CrossMark
Supporting Diversity
CONFERENCE PROCEEDING
COVID-19 and smoking: Worst complications and outcomes
1
Tobacco Prevention and Control Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Publication date: 2022-07-05
Tob. Prev. Cessation 2022;8(Supplement):A91
ABSTRACT
Background:
Few studies have shown that smokers are more likely than nonsmokers to contract COVID-19, while some reports indicate that smokers are underrepresented among those requiring hospital treatment for this illness.
Objective:
This study was designed and implemented to investigate the severity and outcomes of COVID-19, based on underlying smoking status.
Methods:
This was a cross-sectional study that was implemented in Tehran and Ahvaz, with all COVID-19 hospitalized patients, from February to June 2021. A total of 18200 patients with a positive PCR test were observed. A check list of demographic data and smoking history was completed and analyzed.
Results:
In all, 11112 (61.1%) patients were male and the mean age was 47.9±11.3 years; 1508 smokers (8.3%) were seen with any type of tobacco consumption. The frequency of ICU admission in the smokers was significantly higher than non-smokers (23.9% vs 18.8%). Use of more than 3 medications in the smokers was significantly higher (70.6% vs 52%). A comparison between patients based on smoking indicates that the death rate was significantly higher in smokers (31.6% vs 25.6%).
Conclusions:
Smokers with COVID-19 had more severe and worse outcomes.
Few studies have shown that smokers are more likely than nonsmokers to contract COVID-19, while some reports indicate that smokers are underrepresented among those requiring hospital treatment for this illness.
Objective:
This study was designed and implemented to investigate the severity and outcomes of COVID-19, based on underlying smoking status.
Methods:
This was a cross-sectional study that was implemented in Tehran and Ahvaz, with all COVID-19 hospitalized patients, from February to June 2021. A total of 18200 patients with a positive PCR test were observed. A check list of demographic data and smoking history was completed and analyzed.
Results:
In all, 11112 (61.1%) patients were male and the mean age was 47.9±11.3 years; 1508 smokers (8.3%) were seen with any type of tobacco consumption. The frequency of ICU admission in the smokers was significantly higher than non-smokers (23.9% vs 18.8%). Use of more than 3 medications in the smokers was significantly higher (70.6% vs 52%). A comparison between patients based on smoking indicates that the death rate was significantly higher in smokers (31.6% vs 25.6%).
Conclusions:
Smokers with COVID-19 had more severe and worse outcomes.
| eISSN: | 2459-3087 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
